LabelRx: FDA Drug Reference

Pharmacist labels & shortages

Only for iPhone

Free · In‑App Purchases · Designed for iPhone. Not verified for macOS.

iPhone

LabelRx is a clinical drug reference for licensed healthcare professionals — pharmacists, physicians, advanced-practice nurses, residents, and pharmacy/medical students. LabelRx is a clinical drug reference for licensed healthcare professionals — pharmacists, physicians, advanced-practice nurses, residents, and pharmacy/medical students. Free, no ads, no account required. Every FDA prescription drug, every label, every Boxed Warning — searchable in seconds and sourced straight from the authoritative public registries the FDA publishes. — Data sources — • DailyMed (NIH / National Library of Medicine) — the full FDA-approved Structured Product Labeling (SPL) for every U.S. prescription drug • Drugs@FDA — approval history, NDA / ANDA / BLA numbers, sponsors, application letters • FDA Orange Book — therapeutic-equivalence (AB) codes for legal generic substitution, plus active patents and exclusivities • FDA Drug Shortages database — current shortages with reason, discontinuation, and resolution dates • FDA MedWatch — Class I / II / III recalls, enforcement reports, and safety alerts • ClinicalTrials.gov — every registered clinical trial on the approved drug • openFDA FAERS — aggregated post-market adverse event signal by MedDRA term • RxNorm — normalization across brand, generic, and ingredient names • CPIC — Clinical Pharmacogenetics Implementation Consortium gene-drug guidelines — What you get on every drug — • Boxed Warnings front and center, never buried • Dosing organized by indication, with renal and hepatic adjustments surfaced • Contraindications, warnings, and adverse reactions in clinical reading order • Pregnancy and lactation rendered per the FDA PLLR • Orange Book AB codes and therapeutic equivalents for generic substitution • Active patents and exclusivities so you see when generics are likely • Active FDA recalls flagged at the top of the drug • REMS programs surfaced as advisories • Controlled-substance schedule (CI–CV) badge • Pharmacokinetics: half-life, protein binding, dialyzability, CYP substrate / inhibitor / inducer • Pharmacogenomics: CPIC Level A gene-drug guidelines (CYP2C19, CYP2D6, TPMT, UGT1A1, HLA-B, DPYD, SLCO1B1, and more) • Post-market FAERS adverse event signal aggregated by MedDRA term • Clinical trial activity from ClinicalTrials.gov — Clinical calculators — 90+ calculators across nephrology, hepatology, cardiology, ID, psychiatry, oncology, hematology, obstetrics, geriatrics, critical care, and general medicine. Every formula cites primary sources (KDIGO, CKD-EPI 2021, Cockcroft-Gault, MELD 3.0, CHA₂DS₂-VASc, HAS-BLED, Wells, PERC, GRACE, TIMI, Alvarado, Glasgow-Blatchford, Child-Pugh, APACHE II, SOFA, qSOFA, CIWA-Ar, COWS, PHQ-9, GAD-7, AUDIT, EPDS, Bishop, Parkland, ASCVD, Beers Criteria, Schwartz pediatric GFR, Holliday-Segar fluids, Vancomycin AUC/MIC, Opioid MME per CDC 2022, and many more). Every calculator shows its formula, citation, and a clinical-use disclaimer. — Tools — • Renal Dose Adjustment lookup against the actual FDA label text • Substitution Finder using real Orange Book TE codes • Pregnancy & Lactation reference • Drug Shortage tracker (live FDA + ASHP feed) • Pill Identifier by imprint, color, and shape • Label Co-Mentions (label-text search, NOT a validated DDI database) — News & alerts — • FDA new approvals feed, straight from Drugs@FDA • Push notifications for label changes and shortages on drugs you save • Daily clinical assessment to keep your knowledge sharp — Disclaimer — LabelRx is a reference. It is not FDA-cleared as a medical device or as clinical decision support software. Always verify with the current FDA-approved prescribing information, your institutional protocols, and your own clinical judgment. Not a substitute for the full prescribing information or a licensed clinician.

Ratings & Reviews

  • This app hasn’t received enough ratings or reviews to display an overview.

• Today in Rx feed now surfaces only the most recent FDA actions — older revisions no longer show up labeled as today's news. • Adverse-event display is cleaner — better drug-name matching and less duplication on the per-drug FAERS panel. • Faster delivery of future improvements — the app now applies non-binary updates automatically, so reference-data fixes reach you sooner. • Stability and reliability polish across data refresh and UI rendering.

Version 1.0.4

The developer, MEAS Partners, LLC, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .

  • Data Not Linked to You

    The following data may be collected but it is not linked to your identity:

    • Identifiers

Privacy practices may vary, for example, based on the features you use or your age. Learn More

Accessibility

The developer has not yet indicated which accessibility features this app supports. Learn More

Information

Seller
  • MEAS Partners, LLC
Size
  • 46.3 MB
Category
  • Medical
Compatibility
Requires iOS 15.1 or later.
  • iPhone
    Requires iOS 15.1 or later.
  • iPod touch
    Requires iOS 15.1 or later.
  • Mac
    Requires macOS 12.0 or later and a Mac with Apple M1 chip or later.
  • Apple Vision
    Requires visionOS 1.0 or later.
Languages
  • English
Age Rating
16+
In-App Purchases
Yes
  • LabelRx Pro Yearly $39.99
  • LabelRx Pro Monthly $4.99
  • Learn More
Copyright
  • © 2026 MEAS Partners, LLC
  • Developer Website
  • Privacy Policy

    • More by MEAS Partners, LLC

    You Might Also Like